Sign in

Clinical trials

Only want trials near your city that fit you? Get alerts

Reset

1,044 trials

NumberTitleStatusPhaseCountriesSitesRegistry updateFreshness
NCT07897968GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid TumorsNot yet recruitingPhase 1DE13 Nov 2026Fresh (updated this month)
NCT04433221Combination Immunotherapy Targeting SarcomasNot yet recruitingPhase 1/2CN12 Nov 2026Fresh (updated this month)
NCT03356782Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting SarcomasNot yet recruitingPhase 1/2CN130 Oct 2026Fresh (updated this month)
NCT07830667A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to TreatNot yet recruitingPhase 1/2022 Sept 2026Fresh (updated 1 month ago)
NCT07505732Information-providing ChatbotNot yet recruitingNot applicable01 Apr 2026Ageing (updated 7 months ago)
NCT07802652Doxorubicin With or Without DT-7012 in Advanced Soft Tissue SarcomaNot yet recruitingPhase 2FR115 Sept 2026Fresh (updated 1 month ago)
NCT07781891RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCTNot yet recruitingPhase 2US124 Aug 2026Fresh (updated 2 months ago)
NCT07265661Surgical Timing After Preoperative Hypofractionated Radiotherapy for Localized Extremity and Trunk Soft Tissue SarcomaNot yet recruitingNot applicable02 Sept 2026Fresh (updated 2 months ago)
NCT06988007Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a ReferenceNot yet recruitingNot applicableBE129 Apr 2026Ageing (updated 6 months ago)
NCT07743554Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath TumorNot yet recruitingPhase 2028 Oct 2026Fresh (updated this month)
NCT07785882Sarcoma and Intra-infusion Exercise for Better OutcomesNot yet recruitingNot applicableDK125 Aug 2026Fresh (updated 2 months ago)
NCT07905924A Study to Evaluate the Safety and Effectiveness of Different Doses of RO7836748 Alone or in Combination With Other Cancer Therapies in People With Solid Tumors With a Rat Sarcoma Viral Oncogene Homolog Glycine 12 Valine (RAS G12V) MutationNot yet recruitingPhase 1030 Oct 2026Fresh (updated this month)
NCT07054944Tumor-Lymph Node MappingNot yet recruitingNot applicableUS126 Aug 2026Fresh (updated 2 months ago)
NCT07615049Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and RadiationRecruitingPhase 3US6713 Oct 2026Fresh (updated this month)
NCT07861217Paediatric Sarcoma, Hybrid Imaging & FAPI - Raising the Diagnostic Standard for Paediatric Sarcoma Patients, Combining Novel Radiotracer FAPI and Whole-body PET/MRINot yet recruitingPhase 2DK16 Oct 2026Fresh (updated this month)
NCT07823491Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk WallNot yet recruitingPhase 3US116 Sept 2026Fresh (updated 1 month ago)
NCT06500715Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With SarcomaNot yet recruitingNot applicableIL129 Apr 2026Ageing (updated 6 months ago)
NCT07575724Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on Recurrence Rate in Patients With Primary Extremity SarcomaNot yet recruitingPhase 2CN214 Jul 2026Fresh (updated 3 months ago)
NCT07125183Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic LeiomyosarcomaRecruitingPhase 2US15 Feb 2026Ageing (updated 8 months ago)
NCT07576725Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialNot yet recruitingPhase 2UG117 Sept 2026Fresh (updated 1 month ago)

Ordered by registry start date. Freshness and sponsorship never change the order.